Childhood cancer survivors show sustained benefit from common ADHD medication

A medicine widely used to treat attention-deficit/hyperactivity disorder (ADHD) also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors, according to a multicenter trial led by St. Jude Children's Research Hospital investigators.

Read the whole article on Physorg

More from Physorg